Dr. Lai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
430 East 29th Street, 16th Floor
New York, NY 10016
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015
- New York University School of MedicineClass of 2012, MD
Certifications & Licensure
- NY State Medical License 2015 - 2025
- NJ State Medical License 2018 - 2023
- MO State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer Start of enrollment: 2019 Mar 15
Publications & Presentations
PubMed
- 77 citationsTarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.Luis Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan
Journal of Clinical Oncology. 2023-06-01 - 24 citationsRb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.Christopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, Yuhan Wang, Erika Gedvilaite
Clinical Cancer Research. 2022-11-01 - 63 citationsOverall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust
Nature Medicine. 2022-11-01
External Links
- MSKCC Profilehttps://www.mskcc.org/cancer-care/doctors/w-victoria-lai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: